Breast cancer remains a formidable challenge for patients and medical professionals alike. Traditional treatments, such here as chemotherapy and radiation therapy, can be effective but often come with significant side effects. Recently, however, the introduction of immune checkpoint inhibitors like Keytruda has offered a promising avenue for treatm